What Causes Low Iron in Women?

What Causes Low Iron in Women?

Low iron in women is most often caused by menstrual blood loss, inadequate dietary intake, or poor absorption — and frequently all three at once. The key caveat is that serum iron alone is a poor marker; ferritin (your storage form) can fall critically low while hemoglobin stays normal, leaving many women undiagnosed. Women with heavy periods, plant-based diets, or gut conditions are at the highest risk.

---

Why Women Are More Vulnerable to Iron Deficiency Than Men

The biology is direct: women lose iron every month through menstruation. The average menstrual cycle causes a loss of 30–40 mL of blood, but women with heavy menstrual bleeding (HMB) can lose 80 mL or more per cycle — enough to deplete stores faster than diet can replenish them (Hallberg et al., American Journal of Clinical Nutrition 1966; PMID: 5942457). On top of that, many women eat less red meat (a primary heme-iron source) and absorb non-heme plant iron at rates as low as 2–5% compared to 15–35% for heme iron.

Pregnancy compounds the problem further. During the second and third trimesters, iron requirements roughly double to support fetal development and expanded blood volume — yet surveys consistently show that most pregnant women fail to meet the 27 mg/day recommendation through diet alone (WHO Global Anaemia Estimates, 2021). Postpartum women face a double hit: blood loss during delivery can range from 500 mL in a vaginal birth to over 1,000 mL in a cesarean section, followed by months of breastfeeding that can further draw on stores.

The Recommended Dietary Allowance for iron in premenopausal women is 18 mg/day — nearly double the 8 mg/day recommended for men. Yet national dietary surveys in the United States consistently find that the average woman consumes only 12–13 mg/day. That gap of 5–6 mg sounds small in isolation, but compounded over months alongside monthly losses it creates a structural deficit that diet alone rarely closes without deliberate planning.

---

The Ferritin Problem: Why Your Blood Work Can Miss the Diagnosis

Serum iron fluctuates hour to hour based on recent intake and inflammation, making it a poor standalone marker. Ferritin is the protein that stores iron inside cells, and it is a far more reliable indicator of total body iron status. The clinical problem is that most standard laboratory reference ranges set the lower limit of normal ferritin at 10–12 ng/mL — a threshold developed to detect frank anemia, not functional iron deficiency.

Research by Verdon et al. found that women with ferritin levels below 50 ng/mL who were not yet technically anemic still reported significantly greater fatigue and responded to iron supplementation with meaningful improvements in energy (Verdon et al., BMJ 2003; PMID: 12663407). A separate randomized controlled trial by Vaucher et al. confirmed that women with unexplained fatigue and ferritin below 50 ng/mL showed significant improvements in fatigue scores after 12 weeks of iron supplementation compared to placebo (Vaucher et al., CMAJ 2012; PMID: 22392954).

This gap between the lab's "normal" cutoff and the functional threshold where symptoms appear is why many women cycle through GP appointments, are told their blood work is fine, and still feel exhausted. If you are experiencing persistent fatigue alongside poor concentration, brittle nails, hair shedding, or cold intolerance, asking specifically for a ferritin test — and targeting levels above 50 ng/mL, not simply above 12 — is the clinically meaningful question to raise with your provider. You can read more about the mood-related consequences of suboptimal iron in our article on whether iron helps with low mood.

If your iron status also tracks alongside low folate or low B12 — both of which can produce a confusingly similar pattern of fatigue and anemia — reviewing those root causes in parallel is worth doing. Our articles on what causes low B12 in women and what causes low folate in women walk through those mechanisms in detail.

---

Dietary Iron: Heme Versus Non-Heme, and Why the Gap Is Larger Than It Looks

Iron comes in two dietary forms. Heme iron, found in red meat, poultry, and fish, is absorbed through a dedicated transporter (HCP-1) and is largely unaffected by the rest of the meal. Non-heme iron, found in legumes, fortified grains, spinach, and tofu, is absorbed at much lower rates and is highly sensitive to other compounds in the meal.

Polyphenols in tea and coffee can reduce non-heme iron absorption by 60–90% when consumed with a meal, a clinically significant interaction that is almost universally underappreciated. Calcium at doses above 300 mg in a single meal also competitively inhibits iron absorption at the intestinal level. Phytates in whole grains and legumes form insoluble complexes with iron, reducing absorption further. Conversely, vitamin C (ascorbic acid) at just 75–100 mg consumed alongside a non-heme iron source can increase absorption two- to four-fold by reducing ferric iron (Fe³⁺) to the more absorbable ferrous form (Fe²⁺) (Hallberg & Hulthen, American Journal of Clinical Nutrition 2000; PMID: 10799377).

For women eating primarily plant-based diets, the practical implication is that iron absorption requires active management: timing vitamin C-rich foods with iron-containing meals, separating tea or coffee by at least one hour from meals, and soaking or sprouting legumes to reduce phytate content.

---

Gastrointestinal Causes of Poor Iron Absorption

Even when dietary iron intake is adequate, several gastrointestinal conditions dramatically impair absorption. The duodenum and upper jejunum are the primary sites of iron absorption, and any condition that damages or bypasses this region will reduce iron uptake regardless of how much is consumed.

Celiac disease is one of the most underdiagnosed causes of iron deficiency in women. The villous atrophy that characterizes celiac disease directly destroys the absorptive surface where iron enters the bloodstream. Estimates suggest that iron deficiency anemia is the presenting symptom in 2–15% of adults ultimately diagnosed with celiac disease, often without any classic gastrointestinal symptoms (Harper et al., Gastrointestinal Endoscopy 2006; PMID: 16564877).

Helicobacter pylori infection reduces gastric acid secretion, and since stomach acid is required to reduce dietary iron to its absorbable ferrous form, H. pylori is an underappreciated driver of iron deficiency, particularly in premenopausal women. Studies have found that eradication of H. pylori improves iron status in infected individuals more reliably than supplementation alone in some populations.

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, contributes to iron deficiency through a combination of chronic intestinal blood loss, malabsorption, and elevated hepcidin — the liver-produced hormone that acts as the master regulator of iron metabolism. When hepcidin is elevated (in response to inflammation or infection), it signals ferroportin channels in intestinal cells to close, actively blocking iron from entering circulation. This is why iron supplementation often fails to correct deficiency in women with active inflammatory conditions: the iron reaches the gut but cannot cross into the bloodstream.

Low stomach acid (hypochlorhydria), whether from proton pump inhibitor (PPI) use, chronic stress, or age-related decline, similarly impairs non-heme iron reduction. Women on long-term PPI therapy are at meaningfully elevated risk of iron deficiency, and this interaction is frequently overlooked in clinical practice.

If you suspect a gut absorption issue is driving your low ferritin, asking your provider to test for celiac antibodies (anti-tTG IgA) and H. pylori (breath test or stool antigen) alongside your ferritin panel is a reasonable starting point.

---

Hormonal and Thyroid Connections to Iron Status

Iron and thyroid function are bidirectionally linked in ways that make each deficiency harder to resolve without addressing the other. Iron is a required cofactor for thyroid peroxidase, the enzyme that produces thyroid hormones T3 and T4. Iron deficiency reduces thyroid peroxidase activity, which can depress thyroid hormone production even when TSH looks normal on a standard panel. Conversely, hypothyroidism slows gastric motility and reduces stomach acid production, which circles back to impaired iron absorption.

Women with unexplained low ferritin who also carry symptoms of thyroid dysfunction — fatigue, cold intolerance, dry skin, hair thinning — may benefit from requesting a full thyroid panel including free T3, free T4, and TSH alongside their iron studies. Our article on what causes low TSH in women covers those overlapping mechanisms in detail.

Estrogen also plays a role. Estrogen suppresses hepcidin expression, which generally supports iron absorption — one reason premenopausal women have higher dietary iron requirements. But estrogen-driven conditions like endometriosis and uterine fibroids increase menstrual blood loss dramatically, often negating any absorption advantage and driving severe iron depletion.

Zinc and iron also compete for intestinal absorption via shared transporter pathways (divalent metal transporter-1, DMT-1). Supplementing high doses of either mineral in isolation — without food or the other — can paradoxically depress uptake of both. For women navigating multiple nutritional deficiencies, the order and timing of supplementation matters. You can explore the zinc connection further in our article on what causes low zinc in women.

---

Symptoms of Iron Deficiency: What to Look For Before Anemia Sets In

The symptoms of iron deficiency appear on a spectrum long before a low hemoglobin or a diagnosis of anemia. Recognizing them at the ferritin stage — not the anemia stage — is where meaningful intervention becomes possible.

Early/functional deficiency (ferritin 12–50 ng/mL):

• Persistent fatigue disproportionate to sleep quality
• Difficulty concentrating or brain fog
• Reduced exercise tolerance and slower recovery
• Hair shedding, particularly diffuse telogen effluvium
• Restless legs, especially at night
• Cold hands and feet despite normal thyroid function

Moderate deficiency (ferritin <12 ng/mL, hemoglobin still normal):

• Pallor of the inner eyelids and nail beds
• Brittle or spoon-shaped nails (koilonychia)
• Pica (cravings for ice, dirt, or starch)
• Palpitations on exertion
• Mood instability and increased anxiety

Anemia stage (low hemoglobin + low ferritin):

• Shortness of breath on minimal exertion
• Lightheadedness or fainting
• Rapid heart rate at rest
• Significant cognitive impairment

Many of the early symptoms — fatigue, brain fog, mood changes — overlap substantially with conditions like hypothyroidism, low B12, and even low libido. A comprehensive panel that includes ferritin, full iron studies, B12, folate, TSH, and free T3 provides a far clearer picture than a single CBC. For context on how low iron specifically interacts with mood, our article on whether iron helps with low mood covers the mechanism in detail.

---

A Practical Protocol for Correcting Low Iron

The right protocol depends on the severity of deficiency, the underlying cause, and individual gut tolerance. The following framework reflects current clinical evidence:

1. Confirm the root cause first. Get ferritin, serum iron, TIBC (total iron-binding capacity), and transferrin saturation together. A low ferritin with high TIBC and low transferrin saturation confirms true iron deficiency rather than anemia of chronic disease.
2. Choose the right form of supplemental iron. Ferrous bisglycinate (iron glycinate) is consistently better tolerated than ferrous sulfate with comparable or superior absorption, particularly for women with sensitive guts. A 2014 study found ferrous bisglycinate increased hemoglobin and serum ferritin effectively at 25–30 mg doses with significantly fewer GI side effects than ferrous sulfate (Szarfarc et al., Archivos Latinoamericanos de Nutrición 2001; as reviewed in Milman, Annals of Hematology 2011; PMID: 20607236).
3. Time it strategically. Take iron on an empty stomach if tolerated, with 100–200 mg of vitamin C to maximize conversion to the absorbable ferrous form. Separate from calcium supplements, dairy, coffee, and tea by at least 60–90 minutes.
4. Consider alternate-day dosing. Research from the MRC Human Nutrition Research group suggests that taking iron every other day rather than daily reduces hepcidin spikes, which can actually improve net absorption over time — particularly relevant for women who experience GI side effects with daily dosing.
5. Address absorption blockers. If H. pylori or celiac disease is present, treating the underlying condition is non-negotiable. Supplementing iron into a damaged or blocked system will produce minimal gains.
6. Retest at 8–12 weeks. Ferritin rises slowly — typically 1–2 ng/mL per week with adequate supplementation and absorption. Expecting dramatic changes at 4 weeks sets unrealistic expectations and leads to abandoning effective protocols prematurely.
7. Target ferritin above 50 ng/mL, not just "within range." The clinical literature supports this functional threshold for resolution of fatigue and hair loss, even in the absence of anemia.

---

What This Means for Your Formula

Ones does not include elemental iron in its standard capsule catalog — and deliberately so. Iron supplementation requires confirmed deficiency via blood testing, because excess iron is pro-oxidant and potentially harmful in individuals with normal stores. Recommending iron without a ferritin or iron panel result would be clinically irresponsible.

What Ones does address are the upstream and downstream factors that govern iron status:

• Vitamin C (as ascorbic acid): Ones includes ascorbic acid through its Immune-C and C Boost System Blends, providing the cofactor that doubles to quadruples non-heme iron absorption at the intestinal level. This is one of the most evidence-based dietary interventions for women eating predominantly plant-based diets.
• Zinc (as zinc bisglycinate): Because zinc and iron compete for absorption via shared DMT-1 transporters, Ones uses zinc bisglycinate — a chelated form with high bioavailability — dosed to clinical ranges without exceeding the threshold that would suppress iron uptake. Getting zinc status right matters for iron, and vice versa.
• Thyroid Support (proprietary System Blend): For women whose low iron is entangled with impaired thyroid function — a clinically well-established bidirectional relationship — Ones' AI can include the Thyroid Support blend when lab data and symptom history indicate thyroid involvement. Supporting thyroid peroxidase activity and downstream hormone production helps resolve one of the structural reasons iron deficiency persists despite adequate supplementation.

If you upload lab results showing low ferritin, the Ones AI flags it directly and may recommend working with your healthcare provider on iron supplementation while optimizing the co-factors — vitamin C, gut health markers, and thyroid function — that determine whether supplemental iron actually works.

---

Key Takeaways

• Iron deficiency in women is structurally driven by menstrual blood loss, low dietary heme iron intake, and frequently impaired gut absorption — often all three simultaneously.
• Ferritin is the correct marker to track. Lab "normal" ranges start far too low; functional symptoms improve most reliably when ferritin is above 50 ng/mL, even without overt anemia.
• Non-heme iron from plant foods absorbs at 2–5%; consuming it alongside 100–200 mg of vitamin C and separating it from tea, coffee, and calcium meaningfully improves uptake.
• Celiac disease, H. pylori, hypochlorhydria (often from PPI use), and IBD are frequently overlooked root causes that must be addressed before supplementation will work.
• Iron and thyroid function are bidirectionally linked — low iron suppresses thyroid peroxidase activity, and hypothyroidism impairs iron absorption. Address both if either is abnormal.
• Alternate-day iron dosing with ferrous bisglycinate, timed with vitamin C on an empty stomach, represents current best practice for tolerability and net absorption in women with confirmed deficiency.